Relationship of socio-demographics, comorbidities, symptoms and healthcare access with early COVID-19 presentation and disease severity

Table 3 Medical History of COVID-19 Patients Diagnosed in March 2020 at Stanford: Chart review subset

	Total		Outpatient		Inpatient		ER
Known Medical History	N = 257	%^a	N = 127	%^a	N = 34	%^a	N = 96	%^a
Lung condition^b	52	20	27	21	9	27	16	17
BMI 30 + ^***	48	19	23	18	10	29	15	16
Hypertension alone^c***	48	19	20	16	12	35	16	17
Ever smoker^***	43	17	19	15	12	35	12	13
Diabetes^**	35	14	10	8	8	24	17	18
Immunosuppressive condition^d	19	7	10	8	5	15	4	4
Cardiovascular disease^e*	19	7	9	7	6	17	4	4
Neurologic condition^f	14	5	4	3	3	9	7	7
GI condition^g	11	4	6	5	1	3	4	4
GFR <60^h***	11	4	2	2	7	21	2	2
Liver condition^i*	6	2	2	2	2	6	2	2

^a Percentages may not add to 100 due to rounding error
^b Lung conditions include asthma, COPD, chronic lung disease
^c Hypertension without history of cardiovascular disease or poor renal function
^d Immunosuppressive conditions include any of: chronic lung disease, cancer, organ transplant, immunosuppressive drugs, other indicator of immunosuppression
^e Cardiovascular disease includes CAD, myocardial infarction, or heart failure
^f Neurologic conditions include any of: Parkinson Disease, Alzheimer, cognitive impairment, other
^g GI condition includes IBD, IBS, and other
^h only includes those with GFR < 60 prior to diagnosis
ⁱLiver condition includes Hepatitis B, Hepatitis C, Hepatic steatosis, cirrhosis, other
^* P ≤ 0.05
^** P ≤ 0.01
^*** P ≤ 0.001

ISSN: 1471-2334